STAAR Surgical: Growth Story Remains Intact Despite Some Challenges

Shares of STAAR Surgical Company (NASDAQ: STAA ) performed poorly last year, mainly owing to weak consumer demand in its largest market, China. Sales of its EVO lenses as an alternative to LASIK surgery have remained strongAn individual investor primarily focused on undercovered companies, with more than 50 companies on my watchlist. My areas include technology, software, electronics and the energy transition. I have been investing my personal capital for over 7 years in a broad range of companies globally. ...